1. Boehringer Ingelheim International Gmbh (93 from 1,535 patents)

2. Boehringer Ingelheim Pharma Gmbh & Co Kg (11 from 194 patents)

3. Vitae Pharmaceuticals, Inc. (7 from 85 patents)

4. Other (2 from 832,680 patents)

5. Hoechst Schering Agrevo Gmbh (1 from 161 patents)

6. Aventis Cropscience Gmbh (1 from 55 patents)

7. Boehringer Ingelheim Vetmedica Gmbh (306 patents)

1. 12479827 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors

2. 11992494 - Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists

3. 11851418 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors

4. 11766443 - Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists

5. 11760745 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors

6. 11629161 - Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ß-d-glucopyranos-1-yl)-benzene, L-proline and water

7. 11225500 - Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene, L-proline and water

8. 10919859 - Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

9. 10913720 - Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

10. 10793530 - Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

11. 10695334 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors

12. 10603317 - Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

13. 10550127 - Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes

14. 10538490 - Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

15. 10501440 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors